http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-104799147-B
Outgoing Links
| Predicate | Object |
|---|---|
| classificationCPCAdditional | http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A23V2002-00 |
| classificationIPCInventive | http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L29-30 http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A23L33-25 |
| filingDate | 2015-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| grantDate | 2018-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationDate | 2018-08-07-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber | CN-104799147-B |
| titleOfInvention | A kind of composite oligosaccharide prescription |
| abstract | The invention belongs to field of food, and in particular to a kind of composite oligosaccharide prescription.The composite oligosaccharide prescription of the present invention includes the component of following portions by weight：Sucrose：10 30, stachyose 20 30, raffinose 10 20, fructose 5 10, glucose 5 10, pine camphor 0.1 0.5, verbascose 0.05 0.15.Compared with common soyabean oligosaccharides, it is higher containing functional sugar in the composite oligosaccharide prescription of the present invention, that is stachyose and raffinose, and they are inhibited to blood glucose, so aperient effects are apparent after edible, and after diabetes patient, blood glucose value is constant, this is because common soybeans oligosaccharide, then because cane sugar content is higher, stachyose, cottonseed sugared content are relatively low, so without this effect；Composite oligosaccharide prescription also contains pine camphor, verbascose other than containing sucrose, stachyose, raffinose, fructose, glucose. |
| priorityDate | 2015-05-08-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type | http://data.epo.org/linked-data/def/patent/Publication |
Incoming Links
Total number of triples: 55.